Philippe Bourrinet

970 total citations
26 papers, 759 citations indexed

About

Philippe Bourrinet is a scholar working on Radiology, Nuclear Medicine and Imaging, Materials Chemistry and Small Animals. According to data from OpenAlex, Philippe Bourrinet has authored 26 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Materials Chemistry and 3 papers in Small Animals. Recurrent topics in Philippe Bourrinet's work include Lanthanide and Transition Metal Complexes (17 papers), Advanced MRI Techniques and Applications (16 papers) and MRI in cancer diagnosis (10 papers). Philippe Bourrinet is often cited by papers focused on Lanthanide and Transition Metal Complexes (17 papers), Advanced MRI Techniques and Applications (16 papers) and MRI in cancer diagnosis (10 papers). Philippe Bourrinet collaborates with scholars based in France, United States and Moldova. Philippe Bourrinet's co-authors include Bruno Bonnemain, Anne Dencausse, Jean‐Marc Idée, H. H. Bengele, Paula Jacobs, J. Lewis, Claire Corot, Marc Port, Pierre Desché and Nathalie Fretellier and has published in prestigious journals such as Magnetic Resonance in Medicine, Pharmaceutical Research and Journal of Magnetic Resonance Imaging.

In The Last Decade

Philippe Bourrinet

25 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Bourrinet France 14 373 350 192 141 72 26 759
Anne Dencausse France 13 352 0.9× 442 1.3× 306 1.6× 246 1.7× 119 1.7× 23 930
Soraya Benderbous France 16 276 0.7× 322 0.9× 156 0.8× 130 0.9× 63 0.9× 27 658
Stacy Branch United States 9 212 0.6× 300 0.9× 126 0.7× 168 1.2× 127 1.8× 17 741
Gin-Chung Liu Taiwan 13 181 0.5× 157 0.4× 122 0.6× 105 0.7× 108 1.5× 24 528
Ritika Uppal United States 13 387 1.0× 495 1.4× 124 0.6× 122 0.9× 95 1.3× 15 980
Cécile Factor France 15 444 1.2× 609 1.7× 291 1.5× 265 1.9× 84 1.2× 27 1.0k
Yinhua Jin China 16 200 0.5× 249 0.7× 154 0.8× 353 2.5× 178 2.5× 29 859
Levente K. Meszaros United Kingdom 12 423 1.1× 133 0.4× 193 1.0× 201 1.4× 149 2.1× 19 870
Jerry S. Cheung Hong Kong 20 847 2.3× 742 2.1× 142 0.7× 186 1.3× 119 1.7× 33 1.5k
Yanjun Fu United States 18 391 1.0× 183 0.5× 172 0.9× 223 1.6× 153 2.1× 39 970

Countries citing papers authored by Philippe Bourrinet

Since Specialization
Citations

This map shows the geographic impact of Philippe Bourrinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Bourrinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Bourrinet more than expected).

Fields of papers citing papers by Philippe Bourrinet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Bourrinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Bourrinet. The network helps show where Philippe Bourrinet may publish in the future.

Co-authorship network of co-authors of Philippe Bourrinet

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Bourrinet. A scholar is included among the top collaborators of Philippe Bourrinet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Bourrinet. Philippe Bourrinet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lancelot, Eric, et al.. (2025). Safety of Gadoterate Meglumine: A Review of 35 Years of Clinical Use and More Than 170 Million Doses. Investigative Radiology. 60(11). 711–721. 2 indexed citations
2.
Spinazzi, Alberto, Eric Lancelot, Gianpaolo Pirovano, et al.. (2024). Safety of Gadopiclenol After Its First Year of Clinical Use. Investigative Radiology. 60(6). 423–427. 6 indexed citations
3.
Bourrinet, Philippe, et al.. (2023). A Comprehensive Overview of the Efficacy and Safety of Gadopiclenol: A New Contrast Agent for MRI of the CNS and Body. Investigative Radiology. 59(2). 124–130. 24 indexed citations
4.
Bourrinet, Philippe, et al.. (2023). Preclinical Safety Assessment of Gadopiclenol: A High-Relaxivity Macrocyclic Gadolinium-Based MRI Contrast Agent. Investigative Radiology. 59(2). 108–123. 12 indexed citations
5.
Bourrinet, Philippe, et al.. (2021). Pharmacokinetics, Dialysability, and Safety of Gadopiclenol, a New Gadolinium-Based Contrast Agent, in Patients With Impaired Renal Function. Investigative Radiology. 56(8). 486–493. 16 indexed citations
7.
Koob, Mériam, et al.. (2017). A Pharmacokinetics, Efficacy, and Safety Study of Gadoterate Meglumine in Pediatric Subjects Aged Younger Than 2 Years. Investigative Radiology. 53(2). 70–79. 15 indexed citations
8.
Fretellier, Nathalie, et al.. (2015). Non-clinical safety assessment of gadoterate meglumine (Dotarem®) in neonatal and juvenile rats. Regulatory Toxicology and Pharmacology. 73(3). 960–970. 17 indexed citations
9.
Bourrinet, Philippe, Eric Martel, Pascal Champéroux, et al.. (2007). Cardiovascular Safety of Gadoterate Meglumine (Gd-DOTA). Investigative Radiology. 42(2). 63–77. 19 indexed citations
10.
Fan, Xiaobing, Milica Medved, Sean Foxley, et al.. (2006). Multi-Slice DCE-MRI Data Using P760 Distinguishes Between Metastatic and Non-Metastatic Rodent Prostate Tumors. Magnetic Resonance Materials in Physics Biology and Medicine. 19(1). 15–21. 8 indexed citations
11.
Bourrinet, Philippe, H. H. Bengele, Bruno Bonnemain, et al.. (2006). Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent. Investigative Radiology. 41(3). 313–324. 270 indexed citations
12.
Fan, Xiaobing, Milica Medved, Jonathan N. River, et al.. (2004). New model for analysis of dynamic contrast‐enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors. Magnetic Resonance in Medicine. 51(3). 487–494. 80 indexed citations
13.
Port, Marc, Claire Corot, Isabelle Raynal, et al.. (2002). P760. Academic Radiology. 9(1). S17–S19. 3 indexed citations
14.
Corot, Claire, Marc Port, Isabelle Raynal, et al.. (2000). Physical, chemical, and biological evaluations of P760: A new gadolinium complex characterized by a low rate of interstitial diffusion. Journal of Magnetic Resonance Imaging. 11(2). 182–191. 32 indexed citations
15.
Port, Marc, Dominique S. Meyer, Bruno Bonnemain, et al.. (1999). P760 and P775: MRI contrast agents characterized by new pharmacokinetic properties. Magnetic Resonance Materials in Physics Biology and Medicine. 8(3). 172–176. 32 indexed citations
16.
Raynal, Isabelle, et al.. (1998). Nonionic compact dimers: A new generation of isosmolar iodinated contrast media with low viscosity. Academic Radiology. 5(1). 41–48. 5 indexed citations
17.
Bourrinet, Philippe, et al.. (1997). Secretion in Milk and Transplacental Transfer of Two Iodized Oils, Lipiodol UF<sup>®</sup> and Oriodol<sup>®</sup>, in Rabbits. Neonatology. 71(6). 395–402. 4 indexed citations
18.
Bourrinet, Philippe, et al.. (1995). Transplacental Passage and Milk Excretion of Iobitridol. Investigative Radiology. 30(3). 156–158. 15 indexed citations
19.
Bourrinet, Philippe, et al.. (1994). Whole Body Quantitative Autoradiographic Study of the Biodistribution of Iobitridol in Rats. Investigative Radiology. 29(12). 1057–1060. 3 indexed citations
20.
Breton, Pascal, et al.. (1994). Preparation and Characterization of Novel Poly(methylidene Malonate 2.1.2.)-Made Nanoparticles. Pharmaceutical Research. 11(9). 1270–1277. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026